308 related articles for article (PubMed ID: 28258767)
21. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
[TBL] [Abstract][Full Text] [Related]
22. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.
Enninga EAL; Moser JC; Weaver AL; Markovic SN; Brewer JD; Leontovich AA; Hieken TJ; Shuster L; Kottschade LA; Olariu A; Mansfield AS; Dronca RS
Cancer Med; 2017 Oct; 6(10):2203-2212. PubMed ID: 28879661
[TBL] [Abstract][Full Text] [Related]
23. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
Tas F; Kurul S; Camlica H; Topuz E
Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
[TBL] [Abstract][Full Text] [Related]
24. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors and incidence of primary mucosal melanoma: a population-based study in France.
Beaudoux O; Riffaud L; Barbe C; Grange F
Eur J Dermatol; 2018 Oct; 28(5):654-660. PubMed ID: 30378540
[TBL] [Abstract][Full Text] [Related]
26. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the eighth American Joint Committee on Cancer staging system for malignant melanoma of the skin.
Abdel-Rahman O
Future Oncol; 2018 Feb; 14(5):471-481. PubMed ID: 29322826
[TBL] [Abstract][Full Text] [Related]
28. [Clinical characteristics of malignant tumours originating in the external ear].
Gallegos-Hernández JF; Martínez-Méndez MÁ; Ábrego-Vázquez JA; Hernández-Sanjuan M; Minauro-Muñoz GG; Ortiz-Maldonado AL
Cir Cir; 2015; 83(6):473-7. PubMed ID: 26183026
[TBL] [Abstract][Full Text] [Related]
29. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.
Chen VW; Ruiz BA; Hsieh MC; Wu XC; Ries LA; Lewis DR
Cancer; 2014 Dec; 120 Suppl 23(0 0):3781-92. PubMed ID: 25412390
[TBL] [Abstract][Full Text] [Related]
30. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
[TBL] [Abstract][Full Text] [Related]
31. Melanoma surveillance in the United States: overview of methods.
Watson M; Johnson CJ; Chen VW; Thomas CC; Weir HK; Sherman R; Cockburn M; Jackson-Thompson J; Saraiya M
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S6-16. PubMed ID: 22018069
[TBL] [Abstract][Full Text] [Related]
32. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society.
Chang AE; Karnell LH; Menck HR
Cancer; 1998 Oct; 83(8):1664-78. PubMed ID: 9781962
[TBL] [Abstract][Full Text] [Related]
33. Miscoding of Melanoma Thickness in SEER: Research and Clinical Implications.
Gimotty PA; Shore R; Lozon NL; Whitlock J; He S; Vigneau FD; Dickie L; Elder DE; Xu X; Schwartz AG; Guerry D
J Invest Dermatol; 2016 Nov; 136(11):2168-2172. PubMed ID: 27354265
[TBL] [Abstract][Full Text] [Related]
34. Polymorphous low-grade adenocarcinoma of the head and neck: A population-based study of 460 cases.
Patel TD; Vazquez A; Marchiano E; Park RC; Baredes S; Eloy JA
Laryngoscope; 2015 Jul; 125(7):1644-9. PubMed ID: 25877006
[TBL] [Abstract][Full Text] [Related]
35. Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort.
Hieken TJ; Glasgow AE; Enninga EAL; Kottschade LA; Dronca RS; Markovic SN; Block MS; Habermann EB
J Womens Health (Larchmt); 2020 Sep; 29(9):1160-1167. PubMed ID: 32105561
[No Abstract] [Full Text] [Related]
36. Incidence of childhood and adolescent melanoma in the United States: 1973-2009.
Wong JR; Harris JK; Rodriguez-Galindo C; Johnson KJ
Pediatrics; 2013 May; 131(5):846-54. PubMed ID: 23589817
[TBL] [Abstract][Full Text] [Related]
37. The influence of marital status on stage at diagnosis and survival of older persons with melanoma.
Reyes Ortiz CA; Freeman JL; Kuo YF; Goodwin JS
J Gerontol A Biol Sci Med Sci; 2007 Aug; 62(8):892-8. PubMed ID: 17702882
[TBL] [Abstract][Full Text] [Related]
38. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
Eigentler TK; Buettner PG; Leiter U; Garbe C;
J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
[TBL] [Abstract][Full Text] [Related]
39. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
40. Tumor mitotic rate is an independent predictor of survival for nonmetastatic melanoma.
Evans JL; Vidri RJ; MacGillivray DC; Fitzgerald TL
Surgery; 2018 Sep; 164(3):589-593. PubMed ID: 29929753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
